Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Tourmaline Bio Inc (TRML)

  • Technical Exchange News
  • Oct. 29, 2025, 08:54 UTC
  • 0
  • 0 comments

Tourmaline Bio Inc (TRML) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

Tourmaline Bio Inc (TRML)

  • Technical Exchange News
  • Oct. 29, 2025, 07:57 UTC
  • 0
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Tourmaline Bio, Inc. - Common Stock.

Comment Full text

Tourmaline Bio Inc (TRML)

  • Technical Exchange News
  • Oct. 29, 2025, 07:57 UTC
  • 0
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Tourmaline Bio, Inc. - Common Stock.

Comment Full text

Tourmaline Bio Inc (TRML)

  • Technical Exchange News
  • Oct. 29, 2025, 07:57 UTC
  • 0
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Tourmaline Bio, Inc. - Common Stock. New value: Tourmaline Bio, Inc. - Common Stock.

Comment Full text

Entero Therapeutics Inc. (ENTO)

  • Technical Exchange News
  • Oct. 29, 2025, 01:46 UTC
  • 2
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Tourmaline Bio Inc (TRML)

  • Technical Exchange News
  • Oct. 29, 2025, 01:36 UTC
  • 0
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Tourmaline Bio, Inc. - Common Stock.

Comment Full text

Tourmaline Bio Inc (TRML)

  • Technical Exchange News
  • Oct. 29, 2025, 01:36 UTC
  • 0
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Tourmaline Bio, Inc. - Common Stock.

Comment Full text

Tourmaline Bio Inc (TRML)

  • Technical Exchange News
  • Oct. 29, 2025, 01:36 UTC
  • 0
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: Tourmaline Bio, Inc. - Common Stock. New value: Tourmaline Bio, Inc. - Common Stock.

Comment Full text

Entero Therapeutics Inc. (ENTO)

  • Technical Exchange News
  • Oct. 28, 2025, 19:23 UTC
  • 2
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Adaptimmune Therapeutics plc (ADAP)

  • Technical Exchange News
  • Oct. 28, 2025, 08:50 UTC
  • 2
  • 0 comments

Adaptimmune Therapeutics plc (ADAP) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text
  • 1
  • 2
  • 3
  • Next

Search

News categories

  • Technical Exchange News(10286)
  • Event(1436)
  • SEC News(174621)
  • FDA Approval(9632)
  • Company Report(721)
  • Business News(117248)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin